Developing Medical Imaging Drug and Biological Products Part 2: Clinical Indications
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 22, 2004
April 28, 2020
b799f895-2a25-481d-85aa-d8b5f1322a85
Related Documents
Developing Medical Imaging Drug and Biological Products Part 1: Conducting Safety Assessments
Guidance DocumentJune 22, 2004Center for Drug Evaluation and Research
Possible Dioxin/PCB Contamination of Drug and Biological Products
Guidance DocumentAugust 23, 1999Center for Drug Evaluation and Research
Developing Medical Imaging Drug and Biological Products Part 3: Design, Analysis, and Interpretation of Clinical Studies
Guidance DocumentJune 22, 2004Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox